MIMEDX GROUP INC - COMMON STOCK

MIMEDX to Host First Quarter 2022 Operating and Financial Results Conference Call on May 4

20 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

MIMEDX to Present Health Economics Clinical Data for EPIFIX® in Treatment of Lower Extremity Diabetic Ulcers at SAWC Spring

05 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

MIMEDX to Present at the Canaccord Genuity Musculoskeletal Conference

15 Mar 2022 07:00:01 By Nasdaq GlobeNewswire

MIMEDX Announces Fourth Quarter and Full Year 2021 Operating and Financial Results

28 Feb 2022 15:06:03 By Nasdaq GlobeNewswire

Peer-Reviewed Study Demonstrates Increased Cost-Effectiveness of MIMEDX Dehydrated Human Amnion Chorion Membrane (DHACM) in Lower Extremity Diabetic Ulcer (LEDU) Treatment Compared to Standard of Care

16 Feb 2022 07:35:43 By Nasdaq GlobeNewswire

MIMEDX to Host Fourth Quarter 2021 Operating and Financial Results Conference Call on February 28

14 Feb 2022 07:00:01 By Nasdaq GlobeNewswire

MIMEDX Announces Dismissal of Putative Securities Class Action Lawsuit

28 Jan 2022 11:40:00 By Nasdaq GlobeNewswire

MIMEDX Outlines Key Strategic Milestones for 2022

10 Jan 2022 07:00:01 By Nasdaq GlobeNewswire

MIMEDX to Participate at the H.C. Wainwright BioConnect Virtual Conference

04 Jan 2022 15:05:00 By Nasdaq GlobeNewswire

MIMEDX to Present at the 40th Annual J.P. Morgan Healthcare Conference

22 Dec 2021 07:00:00 By Nasdaq GlobeNewswire

MIMEDX Outlines Long-Term Value Creation Strategy at Virtual Investor Day

07 Dec 2021 06:00:01 By Nasdaq GlobeNewswire

MIMEDX Announces Speakers for December 7 Investor Day

30 Nov 2021 07:00:01 By Nasdaq GlobeNewswire

MIMEDX to Present at the Piper Sandler 33rd Annual Healthcare Conference

22 Nov 2021 07:00:02 By Nasdaq GlobeNewswire

Peer Reviewed Study Demonstrates MIMEDX Dehydrated Human Amnion Chorion Membrane (dHACM) Outperforms Standard of Care in Select Mohs Defect Reconstructions

17 Nov 2021 07:00:01 By Nasdaq GlobeNewswire

MIMEDX Announces Third Quarter 2021 Operating and Financial Results

02 Nov 2021 15:50:00 By Nasdaq GlobeNewswire

MIMEDX to Participate at Upcoming Investor Conferences

02 Nov 2021 07:00:03 By Nasdaq GlobeNewswire

Two New Studies Demonstrate in vitro Bioactivity Potential of Micronized Dehydrated Human Amnion Chorion Membrane (mdHACM) to Prevent Pathological Processes Underlying Osteoarthritis (OA) and Tendinopathy

01 Nov 2021 07:30:00 By Nasdaq GlobeNewswire

MIMEDX to Host Third Quarter 2021 Operating and Financial Results Conference Call on November 3

20 Oct 2021 07:00:02 By Nasdaq GlobeNewswire

MIMEDX to Host Virtual Investor Day on December 7, 2021

14 Oct 2021 15:05:00 By Nasdaq GlobeNewswire

MIMEDX Reports Top-line Data from Two Late-Stage Musculoskeletal Trials with Proprietary Amniotic Tissue Technology

13 Sep 2021 05:30:00 By Nasdaq GlobeNewswire